Article
Bayesian meta-analysis of penetrance for cancer risk.
Biometrics - 27 Mar 2024
Ruberu Thanthirige Lakshika M, Braun Danielle, Parmigiani Giovanni, Biswas Swati
Abstract excerpt
Multi-gene panel testing allows many cancer susceptibility genes to be tested quickly at a lower cost making such testing accessible to a broader population. Thus, more patients carrying pathogenic germline mutations in various cancer-susceptibility genes are being identified. This creates a great opportunity, as well as an urgent need, to counsel these patients about appropriate risk-reducing management...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
